These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 3551350)
61. Aminophylline blood levels with concomitant erythromycin therapy in relapsed chronic obstructive lung disease. Vercelloni M; Cogo R; Albertini A; Granata M; Rosaschino F J Int Med Res; 1986; 14(3):131-6. PubMed ID: 3721053 [TBL] [Abstract][Full Text] [Related]
62. Monitoring aminophylline therapy using Jusko's dosage guidelines. Calandre EP; Perez de la Cruz AJ; Morales AM; Alférez NP; Moreno E; Mata GV Intensive Care Med; 1983; 9(2):79-81. PubMed ID: 6853832 [TBL] [Abstract][Full Text] [Related]
63. [Preliminary study on the pharmacokinetics of aminophylline controlled-release tablets]. Lin YG Zhonghua Jie He He Hu Xi Za Zhi; 1988 Feb; 11(1):1-3, 61. PubMed ID: 3197163 [No Abstract] [Full Text] [Related]
64. Is aminophylline useful in chronic obstructive pulmonary disease? When should corticosteroids be used? Figueroa Lebrón R Bol Asoc Med P R; 1988 Sep; 80(9):340. PubMed ID: 3190844 [No Abstract] [Full Text] [Related]
66. [Clinical significance of the determination of serum aminophylline levels]. Xia XR; Kang XM; Tang ZQ Zhonghua Nei Ke Za Zhi; 1985 Jul; 24(7):406-8, 446. PubMed ID: 4053802 [No Abstract] [Full Text] [Related]
67. Aminophylline and chronic obstructive pulmonary disease. Gilchrist D; Chan CK Ann Intern Med; 1988 Mar; 108(3):488. PubMed ID: 3341688 [No Abstract] [Full Text] [Related]
69. Effect of aminophylline on brain tissue oxygenation in patients with chronic obstructive lung disease. Addis GJ Thorax; 1993 May; 48(5):582. PubMed ID: 8322256 [No Abstract] [Full Text] [Related]
70. Aminophylline toxicity. Albert S Pediatr Clin North Am; 1987 Feb; 34(1):61-73. PubMed ID: 3543827 [TBL] [Abstract][Full Text] [Related]
71. [Use of euphylline and zaditen in the treatment of obstructive syndrome in children with allergic diathesis under ambulatory care]. Sirenko OI; Tsuketti AD; Gridneva NN; Bryntsova SS Pediatriia; 1988; (12):74-6. PubMed ID: 3244510 [No Abstract] [Full Text] [Related]
72. Do medications reduce cerebral blood in COPD patients? Young LD; Bowton D; Alford P; McLees B Psychosomatics; 1986 Apr; 27(4):240. PubMed ID: 3704098 [No Abstract] [Full Text] [Related]
73. Possible interaction between aminophylline and ascorbic acid. Furlanut M; Montanari G; Rusca F Br J Clin Pharmacol; 1985 Apr; 19(4):528-9. PubMed ID: 3994901 [No Abstract] [Full Text] [Related]
74. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations]. Wiesner B; Sehrt I; Iwainsky H Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957 [TBL] [Abstract][Full Text] [Related]
75. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease. Fontana G; Cresci F; Lo Sapio P; Panuccio P Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008 [TBL] [Abstract][Full Text] [Related]
76. [Possibilities for optimizing therapy with theophylline preparations. III. Ventilatory effect and pharmacokinetics of "new" Pulmophyllin]. Kandt D; Sehrt I; Iwainsky H Z Erkr Atmungsorgane; 1984; 162(1):18-25. PubMed ID: 6719956 [TBL] [Abstract][Full Text] [Related]
77. Arrhythmias during combined procaterol-aminophylline treatment. A review of the literature and a personal series with dynamic electrocardiography. Galietti F; Giorgis GE; Miravalle C; Oliaro A; Ardizzi A; Barberis S Panminerva Med; 1988; 30(3):173-6. PubMed ID: 2974938 [No Abstract] [Full Text] [Related]
78. [Effect and side effects of a depot theophylline preparation within the scope of a clinical trial]. Wilke A; Weinecke A; Weide W; Schäfer K; Iwainsky H Z Erkr Atmungsorgane; 1986; 167(3):245-53. PubMed ID: 3551350 [TBL] [Abstract][Full Text] [Related]